Tag: Pharmasynthez

Pharmsynthez is a Russian pharmaceutical company that specializes in producing and distributing innovative drugs. The company is able to work in three areas of drug manufacturing, laboratory research and development of new medicines, preparation of original active pharmaceutical ingredients and drugs, and launching products into markets. Such breadth is unusual for Russian pharmaceutical companies.
By constructing its own production facilities, Pharmsynthez will be able to replace contract manufacturing. This will significantly reduce its production costs, allowing it to saving upwards of $2 million per year.

Pharmasyntez and Biocad are in top 10 Russian hospital procurement manufacturers

According to the hospital audit of Russian pharmaceutical market conducted by DSM Group, in 2016, 882.2 million packages of medicinal products worth 221.9 billion rubles were purchased for hospitals i...

Pharmaceutical plant in Bratsk is scheduled for launch in early September

Sergey Levchenko, the Governor of Irkutsk region, made a working visit to Bratsk. At the meeting held in the city administration at the end of his trip, the governor paid a particular attention to the...

New Pharmasyntez plant in Bratsk plans to master up to 45 types of substances

The Bratsk pharmaceutical substances plant (LLC Bratskhimsyntez) which is scheduled for launch this fall, is among the investment projects of Pharmasynthez in the Irkutsk region. The plant is expected...

JSC Pharmasyntez has invested over 2 billion rubles in two new production facilities

New investment projects initiated by the largest enterprises operating in Irkutsk region will be implemented this year. On February 9, Sergey Levchenko, the Governor of Irkutsk region, made the statem...